Please login to the form below

Not currently logged in
Email:
Password:

insuline glargine

This page shows the latest insuline glargine news and features for those working in and with pharma, biotech and healthcare.

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

The decision by the European Medicines Agency (EMA) moves the Lilly/ Boehringer insulin glargine biosimilar, known as LY2963016, one step closer to the market. ... Gwen Krivi, VP, Lilly Diabetes product development, said: "Long-acting insulin is a

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics